Patrick Machado

Director at Alumis · 4 reported transactions in 4 companies · latest report Jun 30, 2026

Their trades


AlumisALMS	Share award — · 3,553 shares	Jun 30, 2026
Xenon PharmaceuticalsXENE	Exercised options — · 2,645 shares	Jun 1, 2026
Adverum BiotechnologiesADVM	Other — · 8,818 shares	Dec 9, 2025
Arcus BiosciencesRCUS	Share award — · 13,300 shares	Jun 10, 2025

Share awardAlumis

Jun 30, 2026 · ALMS

3,553

Jun 1, 2026 · XENE

2,645

Dec 9, 2025 · ADVM

8,818

Jun 10, 2025 · RCUS

13,300

4 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Alumis · 4 reported transactions in 4 companies · latest report Jun 30, 2026


AlumisALMS	Share award — · 3,553 shares	Jun 30, 2026
Xenon PharmaceuticalsXENE	Exercised options — · 2,645 shares	Jun 1, 2026
Adverum BiotechnologiesADVM	Other — · 8,818 shares	Dec 9, 2025
Arcus BiosciencesRCUS	Share award — · 13,300 shares	Jun 10, 2025